Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

被引：0
作者：
Guntulu Ak
Yuji Tada
Hideaki Shimada
Selma Metintas
Masaaki Ito
Kenzo Hiroshima
Masatoshi Tagawa
Muzaffer Metintas
机构：
[1] Eskisehir Osmangazi University,Department of Chest Diseases, Medical Faculty, Lung and Pleural Cancers Research and Clinical Center
[2] Chiba University,Department of Respirology, Graduate School of Medicine
[3] Toho University,Department of Surgery, School of Medicine
[4] Lung and Pleural Cancers Research and Clinical Center,Department of Public Health, Medical Faculty
[5] Eskisehir Osmangazi University,Department of Clinical Oncology, School of Medicine
[6] Toho University,Department of Pathology
[7] Tokyo Women’s Medical University,Department of Molecular Biology and Oncology, Graduate School of Medicine
[8] Yachiyo Medical Center,undefined
[9] Division of Pathology and Cell Therapy,undefined
[10] Chiba Cancer Center Research Institute,undefined
[11] Chiba University,undefined
来源：
BMC Cancer | / 17卷
关键词：
Mesothelioma; Mesothelin; Midkine; Prognosis; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 300 条
  • [1] Husain AN(2009)Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the international Mesothelioma Interest group Arch Pathol Lab Med 133 1317-1331
  • [2] Colby T(2003)Mesothelin family proteins and diagnosis of mesothelioma Lancet 362 1612-1616
  • [3] Ordonez N(2014)Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma Thorax 69 895-902
  • [4] Krausz T(2014)Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis BMJ Open 4 e004145-625
  • [5] Attanoos R(2010)Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma Am J Respir Crit Care Med 181 620-1573
  • [6] Beasley MB(2005)Asbestos exposure, pleural mesothelioma, and serum osteopontin levels N Engl J Med 353 1564-1296
  • [7] Borczuk AC(2014)Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis Int J Clin Exp Med 7 1289-715
  • [8] Butnor K(2013)Hyaluronan and N-ERC/Mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma PLoS One 8 e72030-1427
  • [9] Cagle PT(2014)Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma Mol Cell Proteomics 13 701-2935
  • [10] Chirieac LR(2012)Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma N Engl J Med 367 1417-1324
12345678910